ZA939230B - Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them - Google Patents
Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing themInfo
- Publication number
- ZA939230B ZA939230B ZA939230A ZA939230A ZA939230B ZA 939230 B ZA939230 B ZA 939230B ZA 939230 A ZA939230 A ZA 939230A ZA 939230 A ZA939230 A ZA 939230A ZA 939230 B ZA939230 B ZA 939230B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparing
- compounds
- processes
- carboxylic acid
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4241632A DE4241632A1 (en) | 1992-12-10 | 1992-12-10 | New (aza)aromatic or alicyclic carboxylic acid cpds. - used e.g. for treating thrombosis, inflammation, osteoporosis, cardiac infarct or tumour metastasis |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA939230B true ZA939230B (en) | 1995-06-09 |
Family
ID=6474905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA939230A ZA939230B (en) | 1992-12-10 | 1993-12-09 | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0604800A1 (en) |
JP (1) | JPH06239817A (en) |
KR (1) | KR940014330A (en) |
CN (1) | CN1094035A (en) |
AU (1) | AU5230693A (en) |
CA (1) | CA2111035A1 (en) |
CZ (1) | CZ270593A3 (en) |
DE (1) | DE4241632A1 (en) |
FI (1) | FI935513A (en) |
HU (1) | HU9303521D0 (en) |
IL (1) | IL107956A0 (en) |
MX (1) | MX9307781A (en) |
NO (2) | NO934501L (en) |
NZ (1) | NZ250391A (en) |
PL (1) | PL301396A1 (en) |
SK (1) | SK128193A3 (en) |
ZA (1) | ZA939230B (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4326344A1 (en) * | 1993-08-05 | 1995-02-09 | Thomae Gmbh Dr K | Carbonamides, pharmaceutical compositions containing these compounds and process for their preparation |
AU709070B2 (en) * | 1994-07-15 | 1999-08-19 | Meiji Seika Kabushiki Kaisha | Novel compounds with platelet aggregation inhibitor activity |
GB9514160D0 (en) * | 1994-07-25 | 1995-09-13 | Zeneca Ltd | Aromatic compounds |
GB9417532D0 (en) * | 1994-08-31 | 1994-10-19 | Zeneca Ltd | Aromatic compounds |
GB9420557D0 (en) * | 1994-10-12 | 1994-11-30 | Zeneca Ltd | Aromatic compounds |
US6069143A (en) * | 1994-12-20 | 2000-05-30 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
TW502026B (en) | 1995-06-20 | 2002-09-11 | Zeneca Ltd | Aromatic compounds useful as antagonists of e-type prostaglandins, processes for the preparation thereof, pharmaceutical compositions comprising the compounds, and intermediates |
TW434240B (en) * | 1995-06-20 | 2001-05-16 | Zeneca Ltd | Aromatic compounds, preparation thereof and pharmaceutical composition comprising same |
EP0752421B1 (en) | 1995-07-07 | 2005-10-12 | AstraZeneca AB | Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists |
DE19614204A1 (en) * | 1996-04-10 | 1997-10-16 | Thomae Gmbh Dr K | Carboxylic acid derivatives, medicaments containing these compounds, their use and processes for their preparation |
US5854245A (en) * | 1996-06-28 | 1998-12-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
WO1998037068A1 (en) * | 1997-02-21 | 1998-08-27 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
PL364625A1 (en) | 2001-02-23 | 2004-12-13 | Merck & Co, Inc. | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
EP1599468B1 (en) | 2003-01-14 | 2007-10-03 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
US20070066590A1 (en) * | 2003-02-24 | 2007-03-22 | Jones Robert M | Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism |
US7592360B2 (en) | 2003-06-04 | 2009-09-22 | Merck & Co., Inc. | 3-fluoro-piperidines as NMDA/NR2B antagonists |
AR045047A1 (en) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES |
ES2433466T3 (en) | 2004-02-27 | 2013-12-11 | Amgen, Inc | Compounds, pharmaceutical compositions and methods for use in the treatment of metabolic disorders |
JP4875978B2 (en) * | 2004-03-15 | 2012-02-15 | 武田薬品工業株式会社 | Aminophenylpropanoic acid derivatives |
MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
DOP2006000010A (en) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | PROCEDURE TO PREPARE AROMATIC ETERES |
US7465804B2 (en) | 2005-05-20 | 2008-12-16 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
AU2006291234A1 (en) | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
US7714008B2 (en) | 2006-09-07 | 2010-05-11 | Amgen Inc. | Heterocyclic GPR40 modulators |
AU2007292816B2 (en) | 2006-09-07 | 2011-11-17 | Amgen Inc. | Benzo-fused compounds for use in treating metabolic disorders |
CA2683751C (en) | 2007-04-16 | 2013-01-08 | Amgen Inc. | Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators |
AU2008311355B2 (en) | 2007-10-10 | 2012-01-19 | Amgen Inc. | Substituted biphenyl GPR40 modulators |
WO2009111056A1 (en) | 2008-03-06 | 2009-09-11 | Amgen Inc. | Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
US8748462B2 (en) | 2008-10-15 | 2014-06-10 | Amgen Inc. | Spirocyclic GPR40 modulators |
AU2011305525B2 (en) | 2010-09-22 | 2016-08-18 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
TW201329025A (en) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | Pharmaceutical compounds |
CN116850181A (en) | 2015-01-06 | 2023-10-10 | 艾尼纳制药公司 | Treatment and S1P 1 Methods of receptor-related disorders |
ES2929526T3 (en) | 2015-06-22 | 2022-11-29 | Arena Pharm Inc | (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl) acid L-arginine crystal salt acetic acid for use in disorders associated with the S1P1 receptor |
MA47504A (en) | 2017-02-16 | 2019-12-25 | Arena Pharm Inc | COMPOUNDS AND TREATMENT METHODS FOR PRIMITIVE BILIARY ANGIOCHOLITIS |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4402975A (en) * | 1980-07-21 | 1983-09-06 | Teijin Limited | Aminocarboxylic acids, amino alcohols, or the derivatives thereof, processes for production thereof, and pharmaceutical uses thereof |
DE3718638A1 (en) * | 1987-06-04 | 1988-12-22 | Thomae Gmbh Dr K | NEW PHENYLETHANOLAMINE, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
IL99538A0 (en) * | 1990-09-27 | 1992-08-18 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical compositions containing them |
DE4035961A1 (en) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
DE4102024A1 (en) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | BIPHENYL DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND METHOD FOR THE PRODUCTION THEREOF |
DE4127404A1 (en) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
DE4213931A1 (en) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
DE4213919A1 (en) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
-
1992
- 1992-12-10 DE DE4241632A patent/DE4241632A1/en not_active Withdrawn
-
1993
- 1993-11-17 SK SK1281-93A patent/SK128193A3/en unknown
- 1993-12-08 NZ NZ250391A patent/NZ250391A/en unknown
- 1993-12-08 EP EP93119786A patent/EP0604800A1/en not_active Withdrawn
- 1993-12-08 CA CA002111035A patent/CA2111035A1/en not_active Abandoned
- 1993-12-09 MX MX9307781A patent/MX9307781A/en unknown
- 1993-12-09 NO NO934501A patent/NO934501L/en unknown
- 1993-12-09 IL IL10795693A patent/IL107956A0/en unknown
- 1993-12-09 FI FI935513A patent/FI935513A/en not_active Application Discontinuation
- 1993-12-09 PL PL93301396A patent/PL301396A1/en unknown
- 1993-12-09 HU HU9303521A patent/HU9303521D0/en unknown
- 1993-12-09 NO NO934501D patent/NO934501D0/en unknown
- 1993-12-09 ZA ZA939230A patent/ZA939230B/en unknown
- 1993-12-09 KR KR1019930027010A patent/KR940014330A/en not_active Application Discontinuation
- 1993-12-09 JP JP5308419A patent/JPH06239817A/en active Pending
- 1993-12-10 AU AU52306/93A patent/AU5230693A/en not_active Abandoned
- 1993-12-10 CZ CZ932705A patent/CZ270593A3/en unknown
- 1993-12-10 CN CN93120876A patent/CN1094035A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MX9307781A (en) | 1994-06-30 |
CZ270593A3 (en) | 1994-11-16 |
IL107956A0 (en) | 1994-04-12 |
EP0604800A1 (en) | 1994-07-06 |
CA2111035A1 (en) | 1994-06-11 |
PL301396A1 (en) | 1994-07-25 |
SK128193A3 (en) | 1995-02-08 |
KR940014330A (en) | 1994-07-18 |
AU5230693A (en) | 1994-06-23 |
JPH06239817A (en) | 1994-08-30 |
CN1094035A (en) | 1994-10-26 |
FI935513A (en) | 1994-06-11 |
HU9303521D0 (en) | 1994-04-28 |
DE4241632A1 (en) | 1994-06-16 |
NO934501D0 (en) | 1993-12-09 |
NZ250391A (en) | 1996-06-25 |
FI935513A0 (en) | 1993-12-09 |
NO934501L (en) | 1994-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA937502B (en) | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
ZA939230B (en) | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
ZA93975B (en) | Benzimidazolyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
ZA927994B (en) | Heterobiaryl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
HUT70526A (en) | Indole-2-carboxylic acid derivatives, process for producing thereof and pharmaceutical compositions comprising same compounds | |
IL110296A (en) | Imidazole compounds process for their preparation and pharmaceutical compositions containing them | |
HUT63632A (en) | Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same | |
IL100899A0 (en) | Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUT42101A (en) | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds | |
IL103932A0 (en) | Fatty acid derivatives and pharmaceutical compositions containing them | |
ZA934090B (en) | Biphenyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
HUT69712A (en) | Process for preparing benzimidazole derivatives and pharmaceutical compositions containing them | |
IL108019A0 (en) | Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them | |
IL115072A (en) | Pharmaceutical compositions containing substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation some such new compounds and process for their preparation | |
HUT41737A (en) | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds | |
SG43083A1 (en) | Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them | |
HUT42488A (en) | Process for preparing beta-lactam derivatives and pharmaceutical compositions containing such compounds | |
HUT72319A (en) | Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
ZA933638B (en) | Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them | |
ZA966154B (en) | Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them | |
HU9203866D0 (en) | Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds | |
HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
IL102116A (en) | Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
HU9400325D0 (en) | Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them | |
EG20289A (en) | Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides |